The Dawn of Functional Cures: How Epstein-Barr Virus Research is Redefining Cancer Treatment Nearly 95% of the global population carries the Epstein-Barr virus (EBV), often without knowing it. For most, it’s a harmless childhood infection. But for a significant minority, EBV is a lifelong threat, linked to a spectrum of cancers, including the aggressive follicular … Read more
The relentless search for the root causes of multiple sclerosis (MS) has taken a significant turn, with new research from UCSF pointing to a potentially crucial role for the Epstein-Barr virus (EBV) and a specific type of immune cell. This isn’t simply confirming EBV’s presence – long known to be nearly universal in MS patients … Read more
The Epstein-Barr Virus and Multiple Sclerosis: A New Era of Predictive and Preventative Therapies? Over 94% of individuals with multiple sclerosis (MS) carry the Epstein-Barr virus (EBV), a statistic that has long hinted at a connection. Now, groundbreaking research is moving beyond correlation to demonstrate a causal link, specifically identifying how EBV-induced cross-reactive T cells … Read more